{"company": {"org_id": "T004635621", "org_name_cn": "新天地药业股份有限公司", "org_short_name_cn": "新天地药业", "org_name_en": "Newland Pharmaceutical Co.,Ltd.", "org_short_name_en": "Newland", "main_operation_business": "研发、生产和销售医药中间体、原料药及制剂产品。", "operating_scope": "　　医药中间体、原料药、化学药品制剂的生产、研发和销售（不含危险化学品，且国家禁止经营的产品除外）；货物或技术进出口（国家禁止或涉及行政审批的货物和技术进出口除外）。", "district_encode": "411082", "org_cn_introduction": "新天地药业股份有限公司的主营业务是研发、生产和销售医药中间体、原料药及制剂产品。公司的主要产品是左旋对羟基苯甘氨酸系列产品、对甲苯磺酸。", "legal_representative": "谢建中", "general_manager": "张芦苇", "secretary": "谢雨珊", "established_date": 1126713600000, "reg_asset": 392078399.99999994, "staff_num": 1042, "telephone": "86-374-6103777", "postcode": "461500", "fax": "86-374-6105968", "email": "board@hnnewland.com", "org_website": "www.newlandpharma.com", "reg_address_cn": "河南省许昌市长葛市魏武路南段东侧", "reg_address_en": null, "office_address_cn": "河南省许昌市长葛市魏武路南段东侧", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1668528000000, "provincial_name": "河南省", "actual_controller": "谢建中 (63.21%)", "classi_name": "民营企业", "pre_name_cn": "河南新天地药业股份有限公司", "chairman": "谢建中", "executives_nums": 15, "actual_issue_vol": 33360000.0, "issue_price": 27.0, "actual_rc_net_amt": 815565800.0, "pe_after_issuing": 31.81, "online_success_rate_of_issue": 0.02069071, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}}